Phase II study of cixutumumab (IMC-A12, NSC742460; C) in hepatocellular carcinoma (HCC) Meeting Abstract


Authors: Abou-Alfa, G. K.; Gansukh, B.; Chou, J. F.; Shia, J.; Capanu, M.; Kalin, M.; Chen, H. X.; Zojwalla, N. J.; Katz, S.; Reidy, D. L.; Kelsen, D. P.; Saltz, L.
Abstract Title: Phase II study of cixutumumab (IMC-A12, NSC742460; C) in hepatocellular carcinoma (HCC)
Meeting Title: 47th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 29
Issue: 15 Suppl.
Meeting Dates: 2011 Jun 3-7
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2011-05-20
Language: English
ACCESSION: WOS:000208880300454
DOI: 10.1200/jco.2011.29.15_suppl.4043
PROVIDER: wos
Notes: Meeting Abstract: 4043 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Joanne Fu-Lou Chou
    331 Chou
  2. Leonard B Saltz
    790 Saltz
  3. Seth Stephen Katz
    22 Katz
  4. Ghassan Abou-Alfa
    568 Abou-Alfa
  5. Marinela Capanu
    385 Capanu
  6. Marcia F Kalin
    8 Kalin
  7. Diane Lauren Reidy
    294 Reidy
  8. Jinru Shia
    717 Shia
  9. David P Kelsen
    537 Kelsen
  10. Bolorsukh Gansukh
    15 Gansukh